26.44
Schlusskurs vom Vortag:
$26.51
Offen:
$26.51
24-Stunden-Volumen:
124.44K
Relative Volume:
1.01
Marktkapitalisierung:
$202.51M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-61.23M
KGV:
-1.9557
EPS:
-13.5194
Netto-Cashflow:
$22.49M
1W Leistung:
+8.78%
1M Leistung:
+21.88%
6M Leistung:
+193.28%
1J Leistung:
+52.52%
Assembly Biosciences Inc Stock (ASMB) Company Profile
Firmenname
Assembly Biosciences Inc
Sektor
Branche
Telefon
(833) 409-4583
Adresse
TWO TOWER PLACE, SOUTH SAN FRANCISCO
Vergleichen Sie ASMB mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
ASMB
Assembly Biosciences Inc
|
26.39 | 203.39M | 0 | -61.23M | 22.49M | -13.52 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
407.18 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
471.48 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
552.36 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
![]()
ARGX
Argen X Se Adr
|
808.25 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
![]()
ONC
Beone Medicines Ltd Adr
|
331.09 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Assembly Biosciences Inc Stock (ASMB) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-09-24 | Eingeleitet | Citizens JMP | Mkt Outperform |
2025-08-18 | Fortgesetzt | H.C. Wainwright | Buy |
2025-03-25 | Eingeleitet | Guggenheim | Buy |
2024-09-20 | Hochstufung | Jefferies | Hold → Buy |
2021-09-13 | Eingeleitet | H.C. Wainwright | Neutral |
2021-09-02 | Herabstufung | William Blair | Outperform → Mkt Perform |
2021-03-23 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
2020-11-06 | Herabstufung | Jefferies | Buy → Hold |
2020-10-19 | Eingeleitet | Truist | Buy |
2019-10-16 | Eingeleitet | Mizuho | Buy |
2018-11-19 | Eingeleitet | Leerink Partners | Outperform |
2018-10-08 | Hochstufung | B. Riley FBR | Neutral → Buy |
2018-08-08 | Eingeleitet | Robert W. Baird | Outperform |
2018-04-13 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
2018-01-05 | Eingeleitet | B. Riley FBR, Inc. | Neutral |
2017-11-08 | Eingeleitet | Jefferies | Buy |
2017-05-30 | Eingeleitet | Chardan Capital Markets | Buy |
Alle ansehen
Assembly Biosciences Inc Aktie (ASMB) Neueste Nachrichten
Why Assembly Biosciences Inc. stock could rally in 2025Gap Down & Daily Risk Controlled Trade Plans - newser.com
Real time social sentiment graph for Assembly Biosciences Inc.July 2025 Fed Impact & Smart Money Movement Tracker - newser.com
Will Assembly Biosciences Inc. benefit from macro trendsEarnings Recap Summary & Weekly High Return Stock Opportunities - newser.com
Will Assembly Biosciences Inc. (V7B) stock hit analyst forecastsEarnings Overview Summary & Real-Time Chart Pattern Alerts - newser.com
Why retail investors favor Assembly Biosciences Inc. stockIPO Watch & Long-Term Investment Growth Plans - newser.com
Assembly Biosciences (ASMB) Reports Q1 Loss, Tops Revenue Estimates - MSN
Assembly Biosciences (NASDAQ:ASMB) Shares Cross Above 200-Day Moving AverageTime to Sell? - MarketBeat
Assembly Biosciences (NASDAQ:ASMB) Shares Cross Above 200-Day Moving Average – Time to Sell? - Defense World
Assembly Bio reports positive interim data for genital herpes drug By Investing.com - Investing.com Nigeria
Assembly Biosciences Inc. stock chart pattern explainedQuarterly Profit Report & Risk Managed Investment Strategies - newser.com
Assembly Biosciences (ASMB) Reveals Promising Interim Data for H - GuruFocus
Assembly Biosciences Presents Interim Phase 1b Data for HSV Helicase-Primase Inhibitor Candidate ABI-5366 at the 38th Congress of the International Union Against Sexually Transmitted Infections (IUSTI)- Europe - The Manila Times
Does Assembly Biosciences Inc. show high probability of rebound - newser.com
Will Assembly Biosciences Inc. (V7B) stock outperform small cap peers2025 Price Action Summary & High Conviction Investment Ideas - newser.com
Assembly Biosciences' (ASMB) Sell (D-) Rating Reiterated at Weiss Ratings - MarketBeat
What drives Assembly Biosciences Inc stock priceLong-Term Investment Plans & High Yield Investment Portfolio - earlytimes.in
Using economic indicators to assess Assembly Biosciences Inc. potentialWeekly Trade Analysis & Reliable Entry Point Alerts - newser.com
Will Assembly Biosciences Inc. (V7B) stock outperform benchmarksMarket Performance Report & AI Powered Buy and Sell Recommendations - newser.com
Why analysts upgrade Assembly Biosciences Inc. stock2025 Trading Volume Trends & AI Driven Stock Reports - newser.com
What MACD and RSI say about Assembly Biosciences Inc.Weekly Trade Review & Risk Managed Investment Entry Signals - newser.com
What momentum shifts mean for Assembly Biosciences Inc.Gold Moves & Expert Approved Trade Ideas - newser.com
What indicators show strength in Assembly Biosciences Inc.Weekly Earnings Recap & AI Based Buy/Sell Signal Reports - newser.com
Real time scanner hits for Assembly Biosciences Inc. explainedJuly 2025 Decliners & Fast Exit and Entry Strategy Plans - newser.com
How Assembly Biosciences Inc. (V7B) stock moves on employment dataJuly 2025 Snapshot & AI Forecasted Entry/Exit Points - newser.com
What consensus target says about Assembly Biosciences Inc. (V7B) stockJuly 2025 Highlights & Community Supported Trade Ideas - newser.com
Is Assembly Biosciences Inc. stock entering bullish territoryEarnings Growth Summary & Verified Stock Trade Ideas - newser.com
Does Assembly Biosciences Inc. qualify in momentum factor screeningJuly 2025 Momentum & Fast Entry High Yield Stock Tips - newser.com
Will Assembly Biosciences Inc. (V7B) stock attract long term capital inflowsMarket Volume Summary & Short-Term Trading Opportunity Alerts - newser.com
Visualizing Assembly Biosciences Inc. stock with heatmaps2025 Market WrapUp & Expert Approved Trade Ideas - newser.com
Assembly Biosciences (NASDAQ:ASMB) Share Price Passes Above Two Hundred Day Moving Average – What’s Next? - Defense World
Visual trend scoring systems applied to Assembly Biosciences Inc.Weekly Profit Summary & Safe Capital Investment Plans - newser.com
Assembly Biosciences (NASDAQ:ASMB) Share Price Passes Above Two Hundred Day Moving AverageWhat's Next? - MarketBeat
Assembly Biosciences Inc Stock Analysis and ForecastInflation Impact on Stocks & Start Your Free Trading Journey Today - earlytimes.in
Finanzdaten der Assembly Biosciences Inc-Aktie (ASMB)
Umsatz
Nettogewinn
Free Cashflow
ENV
Assembly Biosciences Inc-Aktie (ASMB) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
Bjorkquist Jeanette M | Principal Accounting Officer |
Mar 31 '25 |
Sale |
9.85 |
180 |
1,773 |
4,617 |
Okazaki Jason A | CEO and President |
Mar 31 '25 |
Sale |
9.85 |
355 |
3,496 |
14,757 |
White Nicole S | Chief Manufacturing Officer |
Mar 31 '25 |
Sale |
9.85 |
197 |
1,940 |
11,674 |
Houghton Michael | Director |
Dec 30 '24 |
Buy |
15.61 |
3,202 |
49,998 |
3,202 |
GILEAD SCIENCES, INC. | 10% Owner |
Dec 19 '24 |
Buy |
21.37 |
940,499 |
20,098,464 |
2,209,471 |
Schornstein Alexander | 10% Owner |
Nov 22 '24 |
Buy |
14.87 |
17,024 |
253,104 |
720,137 |
Schornstein Alexander | 10% Owner |
Nov 25 '24 |
Buy |
14.91 |
7,976 |
118,890 |
728,113 |
White Nicole S | Chief Manufacturing Officer |
Nov 18 '24 |
Sale |
16.29 |
40 |
652 |
11,871 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):